Relay Therapeutics Inc
(RLAY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 134,125 | 152,866 | 143,736 | 151,328 | 145,902 |
| Marketable Securities | 554,290 | 596,742 | 606,350 | 659,287 | 725,671 |
| Receivables | N/A | N/A | N/A | 211 | 78 |
| Other current assets | 5,732 | 7,304 | 3,315 | 3,678 | 3,392 |
| TOTAL | $704,270 | $770,100 | $770,103 | $831,798 | $884,349 |
| Non-Current Assets | |||||
| PPE Net | 8,350 | 9,875 | 10,901 | 10,701 | 11,749 |
| Intangibles | 2,300 | 2,300 | 2,300 | 2,300 | 2,300 |
| Other Non-Current Assets | 57,630 | 59,166 | 60,676 | 62,160 | 63,618 |
| TOTAL | $68,280 | $71,341 | $73,877 | $75,161 | $77,667 |
| Total Assets | $772,550 | $841,441 | $843,980 | $906,959 | $962,016 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 11,167 | 7,973 | 9,211 | 13,353 | 14,778 |
| Accrued Expenses | 27,773 | 22,362 | 14,890 | 31,486 | 26,910 |
| Other current liabilities | 768 | 1,662 | 1,204 | 1,100 | 25,263 |
| TOTAL | $45,043 | $37,144 | $30,269 | $50,748 | $71,576 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | 24 | 15 |
| Other Non-Current Liabilities | 45,763 | 58,533 | 61,708 | 77,838 | 80,321 |
| TOTAL | $45,763 | $58,533 | $61,708 | $77,838 | $80,321 |
| Total Liabilities | $90,806 | $95,677 | $91,977 | $128,586 | $151,897 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 133,890 | 132,742 | 131,179 | 123,269 | 122,134 |
| Common Shares | 133 | 132 | 127 | 123 | 122 |
| Retained earnings | -1,574,181 | -1,481,969 | -1,400,582 | -1,317,087 | -1,251,353 |
| Other shareholders' equity | -1,340 | -1,158 | -196 | -3,386 | -6,081 |
| TOTAL | $681,744 | $745,764 | $752,003 | $778,373 | $810,119 |
| Total Liabilities And Equity | $772,550 | $841,441 | $843,980 | $906,959 | $962,016 |